The Latest Breaking News from Abbott

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Lawsuit filed against Abbott Nutrition over tainted infant formula linked to baby's death, raising awareness about powdered formula risks.

Abbott is warning that sensors on some of its blood sugar monitoring systems may need to be replaced to prevent inaccurate readings

Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.

The stock market rally had some wild moves during the week. The Dow Jones and Russell 2000 jumped, but came off highs. The Nasdaq tumbled.

Abbott stock slumped Thursday despite offering a "clean print" that includes strong growth for its diabetes business and a guidance boost.

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage